# Merck & Co., Inc. – Consensus ‘buy’ rating and 8.6% Upside Potential

- Link: https://www.directorstalkinterviews.com/merck-co.inc.consensus-buy-rating-and-8.6-upside-potential/4121136280
- Published: 2023-12-15T12:21:09+00:00
- Author: Charlotte Edwards

**Merck & Co., Inc.** with ticker code (MRK) have now 26 market analysts covering
the stock. The analyst consensus now points to a rating of ‘buy’. The target price
High/Low ranges between $125.02 and $95.38 suggesting an average Analsyt target 
price of $115.49. Given that the stocks previous close was at $106.34 and the analysts
are correct then we can expect a percentage increase in value of 8.6%. It’s also
worth noting that there is a 50 day moving average of $103.18 and the 200 day moving
average is $108.23. The company has a market cap of 271.42B. The current share price
for the company is: $105.88 USD

 The potential market cap would be $294,773,342,103 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 58.82, revenue per share of $23.38
and a 5.4% return on assets.

Merck & Co., Inc. is a global healthcare company. The Company offers health solutions
through its prescription medicines, including biological therapies, vaccines and
animal health products. It operates through two segments: Pharmaceutical and Animal
Health. The Pharmaceutical segment includes human health pharmaceutical and vaccine
products. Its human health pharmaceutical products consist of therapeutic and preventive
agents, generally sold by prescription for the treatment of human disorders. The
Company sells these human health pharmaceutical products primarily to drug wholesalers
and retailers, hospitals, government agencies and managed healthcare providers, 
such as health maintenance organizations. The Animal Health segment develops, manufactures
and markets a range of veterinary pharmaceutical and vaccine products, as well as
health management solutions and services for the prevention, treatment and control
of disease in all major livestock and companion animal species.

Share on:
